The goal of this randomized controlled trial is to investigate the effect of injection of autologous amniotic fluid in the healing of the scar of cesarean section among high-risk population. Investigator's aim is to know : quality of wound healing, rate of infection and time needed for complete healing. Participants will be divided into two groups. All participants will undergo cesarean section. We will inject autologous amniotic fluid in the edges of the wound during skin closure in half of the participants. Wound healing will be assessed at 1st, 2nd and 6th week postoperatively.

After surgery, participants will be observed along 6 weeks (at 1, 2 and 6 weeks intervals) and scars will be assessed regarding color, thickness, pliability and presence of exudate.

Inclusion Criteria:

• Age > 30 years old.
• Anemic patients
• Maternal chronic disease e.g., Diabetes and Hypertension
• BMI of > 25 Kg/m2.
• Underwent previous CS.

Exclusion Criteria:

• Rupture of membrane.
• No previous section.
• Anhydraminos.
• Congenital malformation of the fetus.